Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 10.3% in First Quarter of 2023

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 144.2 million yuan in the first quarter of 2023, up 10.3% year-on-year.

Meanwhile, the company posted 788.6 million yuan in revenue, up 15.6% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 39.7%.